Optigenex Inc. (OPGX)
Optigenex Inc. operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Melissa, TX, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $17. On trailing twelve-month figures it carries a trailing P/E of 0.00, a net margin of -621.9%. Its beta of 9.71 implies it has historically moved more than the broad market.
Optigenex Inc. is a company dedicated to producing and distributing products that promote healthy aging and enhance beauty. A core offering is AC-11, a potent, powdered extract sourced from rainforest plants. This bioactive ingredient is formulated to assist the body in repairing DNA damage incurred from sun exposure and environmental stressors, thereby contributing to a slowdown in the skin's aging process. Serving a global market, the company supplies its products to manufacturers, distributors, and retailers across various sectors, including dietary supplements, anti-aging topical skincare, cosmetics, and cosmeceuticals. The company's operations are headquartered in Melissa, Texas.
Optigenex Inc. is most often compared with the following Healthcare names: